Alyeska Investment Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.1M Sell
2,112,012
-194,217
-8% -$8.68M 0.23% 115
2026
Q1
$111M Buy
+2,306,229
New +$108M 0.31% 83
2025
Q4
Sell
-1,164,267
Closed -$55M 722
2025
Q3
$55M Buy
1,164,267
+542,850
+87% +$26.2M 0.17% 162
2025
Q2
$30M Buy
621,417
+480,228
+340% +$24.5M 0.11% 221
2025
Q1
$7.83M Sell
141,189
-861,443
-86% -$46.6M 0.03% 332
2024
Q4
$48.4M Sell
1,002,632
-1,777,833
-64% -$90.4M 0.18% 147
2024
Q3
$160M Buy
2,780,465
+1,361,942
+96% +$73.5M 0.82% 20
2024
Q2
$68.8M Buy
+1,418,523
New +$68.4M 0.39% 79
2024
Q1
Sell
-8,716
Closed -$433K 604
2023
Q4
$433K Sell
8,716
-1,317,233
-99% -$64.4M ﹤0.01% 443
2023
Q3
$71.1M Buy
1,325,949
+398,337
+43% +$21.2M 0.48% 63
2023
Q2
$50M Buy
+927,612
New +$49.9M 0.37% 89
2023
Q1
Sell
-610,229
Closed -$29.6M 539
2022
Q4
$29.6M Buy
610,229
+39,513
+7% +$1.73M 0.31% 113
2022
Q3
$21.7M Sell
570,716
-406,859
-42% -$18.1M 0.25% 130
2022
Q2
$48.9M Sell
977,575
-454,489
-32% -$24.1M 0.56% 46
2022
Q1
$73.5M Buy
1,432,064
+360,910
+34% +$18.6M 0.81% 23
2021
Q4
$53.7M Buy
+1,071,154
New +$53M 0.62% 48

Other funds holding SNY

Alyeska Investment Group's SNY Position: Q2 2026 in Review

Alyeska Investment Group reduced its Sanofi (SNY) stake by 8.4% in Q2 2026, selling an estimated $8.68M and leaving 2,112,012 shares worth $90.1M. The position accounts for 0.23% of the portfolio, ranked #115.

Alyeska Investment Group first reported a position in SNY in Q4 2021 and has held it in 16 quarters since. The position peaked at $160M in Q3 2024. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Alyeska Investment Group held 2,112,012 shares of Sanofi worth $90.1M as of Q2 2026.
  • Alyeska Investment Group sold 194,217 Sanofi shares in Q2 2026, an estimated $8.68M.
  • Sanofi made up 0.23% of Alyeska Investment Group's portfolio in Q2 2026, its #115 holding.
  • Alyeska Investment Group first reported a position in Sanofi in Q4 2021 and has held it in 16 quarters since.
  • Alyeska Investment Group's Sanofi position peaked at $160M in Q3 2024.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.